Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neovascular Age-related Macular Degeneration (AMD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01024998
What this trial is testing

Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD)

Who this might be right for
Macular DegenerationAge-Related MaculopathiesAge-Related Maculopathy+7 more
Genzyme, a Sanofi Company 19
Post-approval studies (Phase 4)Study completedNCT01165801
What this trial is testing

Size Progression of Macular Degeneration After Cataract Surgery

Who this might be right for
Age-Related Macular Degeneration
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery 54
Testing effectiveness (Phase 2)Study completedNCT00913744
What this trial is testing

Safety and Efficacy Study of Intravitreal Ocriplasmin in Subjects With AMD With Focal Vitreomacular Adhesion

Who this might be right for
Exudative Age-Related Macular DegenerationFocal Vitreomacular Adhesion
ThromboGenics 100
Testing effectiveness (Phase 2)Study completedNCT00426998
What this trial is testing

Combination Bevacizumab and Verteporfin (Two Different Sequences of Treatment)in Neovascular AMD

Who this might be right for
Choroidal NeovascularizationMacular Degeneration
Retinal Consultants Medical Group 30
Not applicableNot Yet RecruitingNCT07567898
What this trial is testing

Effectiveness of Multidisciplinary Protocolised Interventions on IVT Non-adherence Rates

Who this might be right for
Diabetic Macular EdemaNeovascular (Wet) Age-Related Macular DegenerationIntravitreal Injection
Singapore Eye Research Institute 200
Not applicableStudy completedNCT02304068
What this trial is testing

The Accuracy of Home Monitoring for Acute Macular Degeneration (AMD) Disease Activity

Who this might be right for
Acute Macular Degeneration
The Leeds Teaching Hospitals NHS Trust
Testing effectiveness (Phase 2)Study completedNCT00793923
What this trial is testing

A Prospective Study Comparing Ranibizumab Plus Dexamethasone Combination Therapy Versus Ranibizumab Monotherapy for Wet AMD

Who this might be right for
Exudative Age-Related Macular Degeneration
Subhransu K. Ray, M.D., Ph.D. 40
Testing effectiveness (Phase 2)Study completedNCT00373659
What this trial is testing

An OCT-Guided Variable Dosing Regimen With Ranibizumab for the Treatment of Neovascular AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
University of Miami 40
Not applicableStudy completedNCT05969418
What this trial is testing

Deep Learning Optical Coherence Tomography (OCT) and OCT Angiography (OCTA) in NVC

Who this might be right for
Macular Degeneration Choroidal Neovascularization
Federico II University 50
Post-approval studies (Phase 4)Ended earlyNCT05473715
What this trial is testing

Learn How Well Aflibercept Injected Into the Eye Works and How Safe it is When Given in Customized Treatment Intervals in Patients With an Eye Disease Called Neovascular Age-related Macular Degeneration After Start of Treatment

Who this might be right for
Neovascular (Wet) Age-related Macular Degeneration
Bayer 3
Not applicableStudy completedNCT06699914
What this trial is testing

Evaluate Real-world Brolucizumab Effectiveness and Safety in Japanese Patients With Neovascular Age-related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-Related Macular Degeneration
Novartis Pharmaceuticals 438
Testing effectiveness (Phase 2)Study completedNCT00992563
What this trial is testing

WALTZ - Wet Age-Related Macular Degeneration (AMD) AL-39324 Treatment Examination

Who this might be right for
Age Related Macular Degeneration
Alcon Research 35
Testing effectiveness (Phase 2)Study completedNCT04895293
What this trial is testing

RBM-007 in Treatment naïve Exudative Age-related Macular Degeneration

Who this might be right for
Age Related Macular Degeneration
Maturi, Raj K., M.D., P.C. 5
Not applicableNot Yet RecruitingNCT07744204
What this trial is testing

LEAP Strategy for Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration(nAMD)Wet Macular Degeneration
Chinese PLA General Hospital 240
Large-scale testing (Phase 3)Study completedNCT04777201
What this trial is testing

Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
Hoffmann-La Roche 1,036
Post-approval studies (Phase 4)UnknownNCT02802657
What this trial is testing

Efficacy and Safety of "Treat-and-Extend" Regimen Versus "Pro Re Nata" of Conbercept in Age-related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Xiaodong Sun 141
Not applicableStudy completedNCT03065907
What this trial is testing

Timing of Low Vision Rehabilitation in Anti- Vascular Endothelial Growth Factor (VEGF) Therapy

Who this might be right for
Low VisionNeovascular Age-related Macular Degeneration
Johns Hopkins University 3
Post-approval studies (Phase 4)Study completedNCT00331435
What this trial is testing

PDT Study for Exudative AMD With PCV

Who this might be right for
Age Related Macular Degeneration
Ophthalmic PDT Study Group 113
Testing effectiveness (Phase 2)Study completedNCT05919693
What this trial is testing

A 2-part Study Consisting of Multiple Ascending Dose (MAD) Safety Study, and a Dose-finding Masked Study to Assess the Safety and Efficacy of Intravitreal (IVT) EYE103 in Patients With Diabetic Macular Edema (DME) or Neovascular Age-related Macular Degeneration (NVAMD)

Who this might be right for
Neovascular Age-related Macular Degeneration (NVAMD)Diabetic Macular Edema (DME)
EyeBiotech Ltd. 33
Not applicableStudy completedNCT01032109
What this trial is testing

Photodynamic Therapy Alone Versus Combined With Intravitreal Bevacizumab for Age-related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Kumamoto University 45
Next Page